Scholarlink

Background <p>Human Immunodeficiency Virus (HIV) remains a significant global health challenge despite advancements in prevention and treatment. It impairs immune function and leads to T-cell exhaustion, driven by sustained expression of the immune checkpoint receptor PD-1, which exists in membrane-bound and soluble forms. While serum soluble programmed death protein 1 (sPD-1) may serve as a marker for immune exhaustion, its role in antiretroviral therapy (ART) and intestinal parasite (IP) co-infections remains underexplored, especially in developing countries like Ethiopia with high HIV and IP prevalence. Hence, this study investigates sPD-1 levels in ART-naïve, ART-experienced, and IP co-infected HIV-positive adults at the University of Gondar Comprehensive Specialized Hospital (UOGCSH), Northwest Ethiopia.</p> Methods <p>An institution-based cross-sectional study was conducted among 89 HIV-positive patients from the 1st of May to the 30th of June, 2024, at the UOGCSH. Socio-demographic, clinical, and laboratory data were extracted from a previous project assessing intestinal parasite prevalence in the same population. Quantitative ELISA was used to measure the serum levels of the T cell exhaustion marker, sPD-1. The median serum sPD-1 levels were compared using Kruskal-Wallis and Mann-Whitney U tests. All statistical analyses were conducted using Stata 14 and R version 4.4.0 software. Finally, statistical significance was declared at a p-value of &lt; 0.05.</p> Results <p>Of 89 participants, 64 (71.9%) were ART-experienced, and 43 (48.3%) were IPco-infected. The median serum sPD-1 concentration was significantly higher in the ART-naive group (141.7 pg/mL) compared to ART-experienced counterparts (92.5 pg/mL), (p-value = 0.004). The median sPD-1 levels in the IP co-infected group (117.2 pg/mL) were also significantly higher compared to the IP HIV mono-infected group (77.2 pg/mL), (p-value = 0.0001). Moreover, the presence of IP co-infection significantly increased sPD-1 levels in the ART-experienced group based on a stratified analysis.</p> Conclusion <p>Patients who were ART-naïve, co-infected with intestinal parasites, and had high viral loads exhibited significantly higher levels of sPD-1, suggesting a possible association with increased immune exhaustion. These findings indicate that sPD-1 may have potential as a biomarker for monitoring immune status in HIV-positive individuals. However, further longitudinal and interventional studies are needed to determine its clinical utility in guiding therapeutic decisions.</p> Clinical trial registration <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Serum sPD-1 as a marker of T cell exhaustion in ART-naïve, ART-experienced, and intestinal parasite co-infected HIV-positive adults at the university of Gondar comprehensive specialized hospital, Northwest Ethiopia, 2024

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月27日

查看全文
  • Tadelo Wondmagegn,
  • Wubet Birhan,
  • Eseye Derb,
  • Mulualem Lemma,
  • Hana Yohannes,
  • Degsew Ewunetie Anteneh,
  • Alembante Bazezew,
  • Kebebe Tadesse,
  • Bewuketu Belete Alemu

摘要

Background

Human Immunodeficiency Virus (HIV) remains a significant global health challenge despite advancements in prevention and treatment. It impairs immune function and leads to T-cell exhaustion, driven by sustained expression of the immune checkpoint receptor PD-1, which exists in membrane-bound and soluble forms. While serum soluble programmed death protein 1 (sPD-1) may serve as a marker for immune exhaustion, its role in antiretroviral therapy (ART) and intestinal parasite (IP) co-infections remains underexplored, especially in developing countries like Ethiopia with high HIV and IP prevalence. Hence, this study investigates sPD-1 levels in ART-naïve, ART-experienced, and IP co-infected HIV-positive adults at the University of Gondar Comprehensive Specialized Hospital (UOGCSH), Northwest Ethiopia.

Methods

An institution-based cross-sectional study was conducted among 89 HIV-positive patients from the 1st of May to the 30th of June, 2024, at the UOGCSH. Socio-demographic, clinical, and laboratory data were extracted from a previous project assessing intestinal parasite prevalence in the same population. Quantitative ELISA was used to measure the serum levels of the T cell exhaustion marker, sPD-1. The median serum sPD-1 levels were compared using Kruskal-Wallis and Mann-Whitney U tests. All statistical analyses were conducted using Stata 14 and R version 4.4.0 software. Finally, statistical significance was declared at a p-value of < 0.05.

Results

Of 89 participants, 64 (71.9%) were ART-experienced, and 43 (48.3%) were IPco-infected. The median serum sPD-1 concentration was significantly higher in the ART-naive group (141.7 pg/mL) compared to ART-experienced counterparts (92.5 pg/mL), (p-value = 0.004). The median sPD-1 levels in the IP co-infected group (117.2 pg/mL) were also significantly higher compared to the IP HIV mono-infected group (77.2 pg/mL), (p-value = 0.0001). Moreover, the presence of IP co-infection significantly increased sPD-1 levels in the ART-experienced group based on a stratified analysis.

Conclusion

Patients who were ART-naïve, co-infected with intestinal parasites, and had high viral loads exhibited significantly higher levels of sPD-1, suggesting a possible association with increased immune exhaustion. These findings indicate that sPD-1 may have potential as a biomarker for monitoring immune status in HIV-positive individuals. However, further longitudinal and interventional studies are needed to determine its clinical utility in guiding therapeutic decisions.

Clinical trial registration

Not applicable.